The company said total sales for Q2 in fiscal 2024 were $43.2 billion, up 0.6% from a year earlier, while comparable sales fell 3.3% and U.S. comparable sales fell 3.6%. Total sales include $1.3 billion from the SRS acquisition, covering about 6 weeks of sales.

1. 01

   The company said total sales for Q2 in fiscal 2024 were $43.2 billion, up 0.6% from a year earlier, while comparable sales fell 3.3% and U.S. comparable sales fell 3.6%. Total sales include $1.3 billion from the SRS acquisition, covering about 6 weeks of sales.

2. 02

   The company said operating income for Q2 was $6.5 billion, with an operating margin of 15.1%, below $6.6 billion (15.4%) a year earlier. It said net earnings were $4.6 billion, or $4.60 per diluted share. Adjusted diluted earnings per share were $4.67, compared with $4.68 a year earlier.

3. 03

   The company said it updated its fiscal 2024 outlook to reflect first-half results and the SRS acquisition. It projects total sales growth of 2.5% to 3.5% over 53 weeks, comparable sales decline of 3% to 4% over 52 weeks, and an operating margin rate of 13.5% to 13.6%.

4. 04

   The company recorded a net cash outflow of $17,570 million for business acquisitions, net, net proceeds of $9,952 million from long-term debt issuance and $2,527 million from short-term debt over the 6 months ended July 28, 2024. Share repurchases totaled $649 million over the same period.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.